A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Some professionals stated the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Material Removal
According to the social media company, the service has removed problematic content and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
After minutes of joining one group, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Information and Costs
Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Although the research behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant medical dangers”.
